Lb Pharmaceuticals (LBRX) Non-Current Assets (2024 - 2026)

Lb Pharmaceuticals' Non-Current Assets history runs 3 years deep, the most recent figure standing at $4.4 million for Q1 2026.

• In Q1 2026, Non-Current Assets changed N/A year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $17.9 million (changed N/A YoY), while the FY2025 annual figure was $4.5 million, down 3.29% from the prior year.
• Non-Current Assets was $4.4 million for Q1 2026 at Lb Pharmaceuticals, down from $4.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $4.7 million in Q4 2024 to a low of $4.3 million in Q3 2025.
• Historically, Non-Current Assets has averaged $4.5 million across 3 years, with a median of $4.5 million in 2025.
• Biggest YoY gain for Non-Current Assets was 3.29% in 2025; the steepest drop was 3.29% in 2025.
• A 3-year view of Non-Current Assets shows it stood at $4.7 million in 2024, then declined by 3.29% to $4.5 million in 2025, then decreased by 2.09% to $4.4 million in 2026.
• The last three Non-Current Assets figures came in at $4.4 million (Q1 2026), $4.5 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.